Lung cancer is the leading cancer killer and the most common type of cancer in Hong Kong. In a study, Professor Tony S.K. Mok of The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) and  an international team of experts in lung cancer, found that combining the immunotherapy drugs tremelimumab and durvalumab…